Suppr超能文献

一种新的隐匿性 t(2;3)(p21;q25)易位导致子宫平滑肌瘤中 和 基因融合,3q-是唯一可见的染色体异常。

A Novel Cryptic t(2;3)(p21;q25) Translocation Fuses the and Genes in Uterine Leiomyoma With 3q- as the Sole Visible Chromosome Abnormality.

机构信息

Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway;

Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

出版信息

Cancer Genomics Proteomics. 2022 Sep-Oct;19(5):636-646. doi: 10.21873/cgp.20348.

Abstract

BACKGROUND/AIM: Deletions in the q arm of chromosome 3 have been reported in uterine leiomyomas, also as sole anomalies. Because some neoplasia-associated deletions may give rise to tumorigenic fusion genes, we chose to investigate thoroughly one such tumor.

MATERIALS AND METHODS

A uterine leiomyoma obtained from a 45-year-old woman had the karyotype 46,XX,del(3)(q?)[11]. The tumor was further studied using array comparative genomic hybridization, RNA sequencing, reverse transcription polymerase chain reaction, Sanger sequencing, and fluorescence in situ hybridization methodologies.

RESULTS

The deletion was shown to be from 3q22.2 to 3q26.32. Unexpectedly, a cryptic balanced t(2;3)(p21;q25) translocation was also found affecting two otherwise normal chromosomes 2 and 3, i.e., the der(3)t(2;3) was not the deleted chromosome 3. The translocation generated two chimeras between the genes WW domain containing transcription regulator 1 (WWTR1) from 3q25.1 and protein kinase C epsilon (PRKCE) from 2p21. The WWTR1::PRKCE fusion would code for a chimeric serine/threonine kinase, whereas the reciprocal PRKCE::WWTR1 fusion would code for a chimeric transcriptional coactivator protein.

CONCLUSION

Leiomyomas carrying a deletion on 3q may also have a balanced t(2;3)(p21;q25) leading to fusion of WWTR1 with PRKCE.

摘要

背景/目的:染色体 3q 臂缺失已在子宫平滑肌瘤中报道,也作为单一异常。因为一些与肿瘤相关的缺失可能导致致瘤性融合基因,所以我们选择深入研究一个这样的肿瘤。

材料和方法

一个来自 45 岁女性的子宫平滑肌瘤的核型为 46,XX,del(3)(q?)[11]。使用阵列比较基因组杂交、RNA 测序、逆转录聚合酶链反应、Sanger 测序和荧光原位杂交方法进一步研究肿瘤。

结果

缺失被证明来自 3q22.2 到 3q26.32。出乎意料的是,还发现了一个隐匿性平衡易位 t(2;3)(p21;q25),影响了两个正常的染色体 2 和 3,即衍生染色体 3 不是缺失的染色体 3。易位产生了两个来自 3q25.1 的 WW 结构域包含转录调节剂 1(WWTR1)和来自 2p21 的蛋白激酶 C epsilon(PRKCE)之间的嵌合体基因。WWTR1::PRKCE 融合将编码一个嵌合丝氨酸/苏氨酸激酶,而相反的 PRKCE::WWTR1 融合将编码一个嵌合转录共激活蛋白。

结论

携带 3q 缺失的平滑肌瘤也可能具有平衡的 t(2;3)(p21;q25),导致 WWTR1 与 PRKCE 融合。

相似文献

2
Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma.
Sci Transl Med. 2011 Aug 31;3(98):98ra82. doi: 10.1126/scitranslmed.3002409.
3
A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites.
Genes Chromosomes Cancer. 2011 Aug;50(8):644-53. doi: 10.1002/gcc.20886. Epub 2011 May 16.
4
Fusion of the and Genes in Uterine Leiomyoma With t(9;12)(p22;q14).
In Vivo. 2022 Nov-Dec;36(6):2654-2661. doi: 10.21873/invivo.13000.
5
Several Fusion Genes Identified in a Spermatic Cord Leiomyoma With Rearrangements of Chromosome Arms 3p and 21q.
Cancer Genomics Proteomics. 2021 Jul-Aug;18(4):531-542. doi: 10.21873/cgp.20278.
6
Fusion of the Genes and in Pseudomyogenic Hemangioendothelioma.
Cancer Genomics Proteomics. 2019 Jul-Aug;16(4):293-298. doi: 10.21873/cgp.20134.
9
Characterization of a recurrent t(1;2)(p36;p24) in human uterine leiomyoma.
Cancer Genet Cytogenet. 2009 Aug;193(1):54-62. doi: 10.1016/j.cancergencyto.2009.03.011.

引用本文的文献

1
Genetic Pathways in Peritoneal Mesothelioma Tumorigenesis.
Cancer Genomics Proteomics. 2023 Jul-Aug;20(4):363-374. doi: 10.21873/cgp.20388.
2
Acute Undifferentiated Leukemia With a Balanced t(5;10)(q35;p12) Resulting in Fusion of With .
Cancer Genomics Proteomics. 2023 Jul-Aug;20(4):354-362. doi: 10.21873/cgp.20387.
3
Recurrent 8q11-13 Aberrations Leading to Rearrangements, Including Novel Chimeras and , in Lipomatous Tumors.
Cancer Genomics Proteomics. 2023 Mar-Apr;20(2):171-181. doi: 10.21873/cgp.20372.
4
Novel and Fusion Genes in T-cell Acute Lymphoblastic Leukemia.
Cancer Genomics Proteomics. 2023 Jan-Feb;20(1):51-63. doi: 10.21873/cgp.20364.
5
Fusion of the and Genes in Uterine Leiomyoma With t(9;12)(p22;q14).
In Vivo. 2022 Nov-Dec;36(6):2654-2661. doi: 10.21873/invivo.13000.

本文引用的文献

1
A novel WWTR1::AFF2 fusion in an intra-abdominal soft tissue sarcoma with associated endometriosis.
Genes Chromosomes Cancer. 2022 Aug;61(8):497-502. doi: 10.1002/gcc.23045. Epub 2022 Apr 26.
2
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer.
Clin Sci (Lond). 2022 Feb 11;136(3):197-222. doi: 10.1042/CS20201474.
3
Interstitial Deletions Generating Fusion Genes.
Cancer Genomics Proteomics. 2021 May-Jun;18(3):167-196. doi: 10.21873/cgp.20251.
4
Epithelioid hemangioma of bone harboring FOS and FOSB gene rearrangements: A clinicopathologic and molecular study.
Genes Chromosomes Cancer. 2021 Jan;60(1):17-25. doi: 10.1002/gcc.22898. Epub 2020 Oct 9.
5
and Fusion Genes in Chondroid Syringoma.
Cancer Genomics Proteomics. 2020 May-Jun;17(3):237-248. doi: 10.21873/cgp.20184.
6
Fusion of the Genes and in Pseudomyogenic Hemangioendothelioma.
Cancer Genomics Proteomics. 2019 Jul-Aug;16(4):293-298. doi: 10.21873/cgp.20134.
7
Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
J Clin Invest. 2019 May 30;129(9):3827-3832. doi: 10.1172/JCI126185.
8
Impact of uterine fibroids on quality of life: a national cross-sectional survey.
Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:32-37. doi: 10.1016/j.ejogrb.2018.07.032. Epub 2018 Aug 1.
9
Multifaceted regulation and functions of YAP/TAZ in tumors (Review).
Oncol Rep. 2018 Jul;40(1):16-28. doi: 10.3892/or.2018.6423. Epub 2018 May 8.
10
Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata.
Cancer Genet. 2018 Apr;222-223:1-8. doi: 10.1016/j.cancergen.2018.01.001. Epub 2018 Feb 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验